This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer. * The phase 1 study will evaluate the feasibility and safety of delivering SMART in patients with cancer. * Phase 2 will evaluate efficacy of SMART with specific reference to tumor control and improvement in patient reported outcome measures
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Delivery Success Rate for SMART across multiple tumors-Phase I
Timeframe: 1 year
Tumor visualization-Phase I
Timeframe: 1 Year
Plan creation-Phase I
Timeframe: 1 Year
Rate of Improvement in Tumor Control-Phase II
Timeframe: 1 Year